Sirnaomics Ltd (2257)

Hong Kong
Currency in HKD
2.96
+0.02(+0.68%)
Closed·
2257 Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
2.952.99
52 wk Range
2.3510.32
Key Statistics
Edit
Bid/Ask
2.96 / 2.99
Prev. Close
2.94
Open
2.95
Day's Range
2.95-2.99
52 wk Range
2.35-10.32
Volume
14.1K
Average Volume (3m)
193.25K
1-Year Change
-51.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2257 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
71.93
Upside
+2,329.91%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Sirnaomics Ltd Company Profile

Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs. The company’s therapeutics products focus on oncology and fibrosis, anticoagulant therapies, cardiometabolic disease, complement-mediated diseases, medical aesthetics, and viral infections. Its lead drug candidates include STP705 for the treatment of non-melanoma skin cancer and for focal fat reduction; and STP707 to treat solid tumors. The company is also developing STP355 for the treatment of multiple solid tumors, including breast cancer, melanoma, and colorectal cancer; STP369 to treat head and neck and bladder cancer; STP705 for focal fat reduction; STP122G to treat coagulation disorders; STP125G to treat hypertriglyceridemia; and STP144G for the treatment of complement diseases. In addition, it is developing RV-1730, a Covid-19 vaccine; RV-1770, a respiratory syncytial virus vaccine; STP247G, STP144G, STP145G, and STP146G for the treatment of complement diseases; STP152G for ATTR amyloidosis indication; STP136G to treat hypertension; STP251G for treating hemochromatosis and hypertriglyceridemia; and STP237G to treat hypertension and hypertriglyceridemia. The company was founded in 2007 and is based in Wan Chai, Hong Kong.

Compare 2257 to Peers and Sector

Metrics to compare
2257
Peers
Sector
Relationship
P/E Ratio
−0.8x−0.5x−0.5x
PEG Ratio
−0.020.040.00
Price/Book
−23.7x2.3x2.6x
Price / LTM Sales
22.4x10.9x2.9x
Upside (Analyst Target)
-321.1%57.8%
Fair Value Upside
Unlock16.2%10.2%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 71.93
(+2,329.91% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Sirnaomics (2257) Stock Price Today?

The Sirnaomics stock price today is 2.96

What Stock Exchange Does Sirnaomics Trade On?

Sirnaomics is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Sirnaomics?

The stock symbol for Sirnaomics is "2257."

What Is the Sirnaomics Market Cap?

As of today, Sirnaomics market cap is 308.86M.

What is Sirnaomics Earnings Per Share?

The Sirnaomics EPS is -0.66.

From a Technical Analysis Perspective, Is 2257 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.